"
Template:SupbiotechparisFr
From 2009.igem.org
(Difference between revisions)
Enguerrand (Talk | contribs) |
Enguerrand (Talk | contribs) |
||
| Line 32: | Line 32: | ||
<div id="menuhaut"> | <div id="menuhaut"> | ||
{| style="background-color: transparent;" cellpadding="3" cellspacing="20" align="center" | {| style="background-color: transparent;" cellpadding="3" cellspacing="20" align="center" | ||
| - | !align="center"|[[Team:SupBiotech-Paris/HomeFr#firstHeading|Accueil]] | + | !align="center"|[[Team:SupBiotech-Paris/HomeFr#.firstHeading|Accueil]] |
!align="center"|[[Team:SupBiotech-Paris/Equipe|Equipe]] | !align="center"|[[Team:SupBiotech-Paris/Equipe|Equipe]] | ||
!align="center"|[[Team:SupBiotech-Paris/Gestion de projet|Gestion de projet]] | !align="center"|[[Team:SupBiotech-Paris/Gestion de projet|Gestion de projet]] | ||
Revision as of 22:18, 22 September 2009
Projet
Introduction Thérapies actuelles Thérapies géniques Concept DVS Introduction Vecteur Tissulaire Vecteur Cellulaire Plasmide d'apoptose Conclusion Mise en application Ciblage Tissulaire Ciblage Cellulaire Modélisation cancer Conclusion
Ressources
Biobricks Matériel & Méthode Bibliographie
Ethique & sûreté
Biologie Synthetique Notre projet Sûreté
